Recombinant Human Transmembrane protein 242 (TMEM242)

Basic Research Questions

• What is the basic structure and localization of human TMEM242?

  TMEM242 is a 141 amino acid transmembrane protein encoded by a gene located on chromosome 6q25.3 containing 4 exons. The protein contains a DUF1358 domain (Domain of Unknown Function 1358). Subcellular fractionation and immunofluorescence microscopy confirm that TMEM242 localizes exclusively to mitochondria. It is an integral component of the inner mitochondrial membrane (IMM) as demonstrated by alkaline pH washing experiments, where it resists extraction but can be solubilized with deoxycholate concentrations of 0.5% or greater. Topological studies using trypsinolysis of intact and lysed mitochondria reveal that both N- and C-terminal regions of TMEM242 face the mitochondrial matrix .

• What is the primary function of TMEM242 in mitochondria?

  TMEM242 functions as a scaffold protein that participates in the assembly of the c8-ring of mitochondrial ATP synthase (F1F0 ATP synthase or complex V). ATP synthase is assembled from 29 component proteins (18 different types), with ATP6 and ATP8 encoded by mitochondrial genes while the remainder are nuclear gene products imported into mitochondria. TMEM242 facilitates membrane insertion and oligomer formation of subunit c/ATP5MC3, helping to form the membrane sector of the enzyme's rotor. Additionally, it influences the incorporation of subunits MT-ATP6, MT-ATP8, ATP5MJ, and ATP5MK into the ATP synthase complex .

• How does TMEM242 interact with other proteins involved in ATP synthase assembly?

  TMEM242 works in conjunction with another transmembrane protein, TMEM70, to facilitate ATP synthase assembly. Both proteins interact directly with subunit c of ATP synthase, forming high molecular mass complexes with the c-subunit in the range of 60 to 150 kDa. Additionally, both TMEM242 and TMEM70 interact with the mitochondrial complex I assembly (MCIA) complex, which supports assembly of the membrane arm of complex I. TMEM242 has also been shown to interact with proteins including GGT7 and RNF5. Known and predicted interactors also include MAP2K1IP1 (a scaffold protein involved in the MAP Kinase pathway), and multiple other proteins including ELOVL4, GPR42, BCL2L13, and HEATR1 .

Advanced Research Questions

• What are the differential effects of TMEM242 deletion versus TMEM70 deletion on respiratory chain complexes?

  Deletion studies reveal distinct impacts of TMEM242 and TMEM70 on respiratory complexes:

  Deletion	ATP Synthase	Complex I	Complex III	Complex IV	Notes
  ΔTMEM70	Reduced but present	Reduced	Minimal effect	Minimal effect	F1-PS-c8-e-f-g subcomplexes predominate
  ΔTMEM242	Reduced	Reduced	Reduced	Reduced	F1-PS-e-f-g subcomplexes predominate
  ΔTMEM70.ΔTMEM242	Nearly absent	Severely reduced	Reduced	Reduced	Enhanced impact on ATP6, ATP8, j, k subunits

  While TMEM70 primarily affects ATP synthase and complex I assembly, TMEM242 has a broader impact, affecting complexes I, III, and IV. TMEM242 deletion selectively diminishes incorporation of subunits ATP6, ATP8, j, and k into ATP synthase. Double deletion of both proteins prevents ATP synthase assembly completely and has an enhanced impact on complex I assembly .

• How does TMEM242 contribute to the sequential assembly pathway of ATP synthase?

  Research indicates TMEM242 plays specific roles in multiple stages of ATP synthase assembly:

  1. Early stage: Facilitates the integration of subunit c into the inner mitochondrial membrane

  2. Middle stage: Participates in the formation of c8-rings

  3. Late stage: Influences the incorporation of membrane subunits ATP6, ATP8, j, and k

  The assembly sequence appears to be: after the c8-ring incorporation into the F1-PS-c8-e-f-g subcomplex, subunits ATP6 and ATP8 are added, followed by subunit j (which stabilizes binding of ATP6 and ATP8), and finally subunit k. TMEM242 is particularly critical for these terminal assembly steps, whereas TMEM70 appears to function primarily in earlier stages. This explains why deletion of TMEM242 results in decreased levels of ATP6, ATP8, j, and k in vestigial ATP synthase complexes .

• What are the physiological consequences of TMEM242 deficiency in zebrafish models and their potential implications for human disease?

  Recent research (2025) using zebrafish tmem242 knockdown models reveals unexpected systemic effects:

  Parameter	Effect of tmem242 knockdown	Mechanism
  Hemostasis	Enhanced gill bleeding	DIC-like conditions
  Thrombocyte count	No significant change	-
  Blood aggregation	No significant change	-
  Coagulation	Delayed (kPTT and kPT assays)	Sequestration of clotting factors
  Clotting factor genes	Increased (except f8)	ROS-mediated upregulation
  f9a mRNA	>10-fold increase	ROS→sirt6→nrf2 pathway
  Reactive oxygen species	Significantly increased	Impaired ATP synthase
  Microthrombi	Present in larvae	Factor sequestration

  The mechanism appears to involve: tmem242 deficiency → impaired ATP synthase assembly → increased ROS → activation of sirt6 and nrf2 → upregulation of coagulation factors → DIC-like bleeding. This suggests TMEM242 deficiency could potentially contribute to coagulation disorders in humans through mitochondrial dysfunction-driven ROS production .

Methodological Research Questions

• What approaches can be used to effectively knock down TMEM242 expression in animal models?

  Research demonstrates successful TMEM242 knockdown using the following methodologies:

  1. Piggyback knockdown in zebrafish: This approach achieved >95% knockdown efficiency as verified by qRT-PCR. The method involves antisense oligonucleotides designed specifically against tmem242.

  2. CRISPR-Cas9 deletion in cell lines: HAP1 cells with TMEM242 deletion (HAP1-ΔTMEM242) have been successfully generated, as well as double knockout lines (HAP1-ΔTMEM70.ΔTMEM242).

  3. Verification methods:

     • qRT-PCR using tmem242-specific primers to confirm transcript reduction

     • Western blotting to verify protein depletion

     • Functional assays (ATP synthase assembly, oxygen consumption, oligomycin sensitivity)

  When designing knockdown experiments, it's important to include appropriate controls and verify knockdown efficiency at both mRNA and protein levels. For zebrafish models specifically, embryos at 3 days post-fertilization (dpf) can be injected with knockdown constructs and assessed at 5-dpf for phenotype development .

• What methods are optimal for studying TMEM242 protein interactions in mitochondrial membrane complexes?

  Several complementary approaches have proven effective for studying TMEM242 interactions:

  1. Affinity purification with tagged TMEM242:

     • C-terminal Strep II and FLAG tags (TMEM242-t) in HEK293 cells

     • N-terminal FLAG tag (TMEM242-Nt) in HeLa cells

     • Purification via one-step affinity chromatography

  2. Cross-linking coupled with mass spectrometry:

     • Identifies transient or weak interactions within membrane complexes

     • Preserves the native membrane environment

  3. Blue Native PAGE (BN-PAGE):

     • Effective for resolving intact ATP synthase and subcomplexes

     • Can be combined with second-dimension SDS-PAGE for subunit identification

  4. Quantitative proteomics:

     • Comparison of wild-type vs. ΔTMEM242 mitochondrial fractions

     • Identifies changes in complex assembly and stability

  5. Co-immunoprecipitation:

     • Using antibodies against TMEM242 or potential interacting partners

     • Identifying components of MCIA complex interactions

  These techniques have revealed TMEM242 interactions with subunit c of ATP synthase and components of the MCIA complex. For optimal results, mitochondrial isolation should be performed under conditions that preserve membrane protein interactions .

• How can the impact of TMEM242 on mitochondrial function be comprehensively assessed?

  A multi-parameter approach is recommended for evaluating TMEM242's impact on mitochondrial function:

  1. ATP synthase assembly:

     • Blue Native PAGE followed by Western blotting for ATP synthase subunits

     • Quantitative proteomics of purified ATP synthase complexes

     • Immunodetection of specific subunits (c, ATP8, j)

  2. Respiratory chain function:

     • Oxygen consumption measurements with substrate-specific inhibitors

     • Assessment of oligomycin-sensitive respiration

     • Blue Native PAGE analysis of complexes I, III, and IV

  3. ROS production:

     • DCHF-DA (2′,7′-dichlorodihydrofluorescein diacetate) fluorescence assay

     • Quantitative image analysis of fluorescence intensity

     • Comparison with ATP synthase inhibitors (e.g., oligomycin)

  4. Membrane potential:

     • Potentiometric dyes such as TMRM or JC-1

     • Flow cytometry or confocal microscopy analysis

  5. ATP production:

     • Luciferase-based ATP assays

     • Comparison with glycolytic ATP production

  This comprehensive approach has revealed that TMEM242 deficiency impacts not only ATP synthase assembly but also leads to broader effects on respiratory chain complexes and cellular ROS levels .

• What expression systems are most effective for producing recombinant TMEM242 protein for structural and functional studies?

  Multiple expression systems have been successfully employed for TMEM242 production:

  Expression System	Tag Options	Purity	Applications	Considerations
  HEK293 cells	His6, Strep II, FLAG	>90%	Functional studies, Pull-downs	Mammalian PTMs preserved
  E. coli	His6-ABP	Variable	Antigen production, Antibody blocking	Limited for functional studies
  Cell-free protein synthesis	Strep Tag	70-80%	Rapid screening, Small-scale studies	Lower yield

  For structural and functional studies of human TMEM242, mammalian expression systems (particularly HEK293) are preferred as they maintain proper folding and post-translational modifications. His-tagged constructs (AA 1-141) have been successfully produced with >90% purity as determined by Bis-Tris PAGE, anti-tag ELISA, Western Blot and analytical SEC. For optimal purification, one-step affinity chromatography is typically used, with buffer composition often containing mild detergents to maintain the native conformation of this transmembrane protein .